Additional
Data MRI Most Effective for Breast Cancer Detection in High-Risk
Young Women
According to a recent presentation at the 39th annual meeting
of the American Society of Clinical Oncology, magnetic resonance
imaging (MRI) appears superior to mammography and ultrasound
imaging in early detection of breast cancer in high-risk women.
Individuals with strong family histories and/or mutations
within the BRCA1 or BRCA2 genes have a high risk of developing
breast cancer within their lifetime. Women with these mutations
have to make a decision as to whether preventive surgery or
frequent monitoring for the development of breast cancer will
provide the most reassuring option for them. Self breast exams,
mammography and ultrasound imaging are all frequently used
for monitoring of breast cancer. However, since young women
have more dense breasts, mammography often cannot pick up
small cancers.
Researchers from Germany recently conducted a clinical trial
to compare the effectiveness of magnetic resonance imaging
(MRI), ultrasonography or mammography in women who were at
a high risk of developing breast cancer. This trial included
women with a strong family history of breast cancer or women
who had mutations within the BRCA1 and/or BRCA2 genes. Screening
including MRI, ultrasound and mammography were initiated at
the age of 30 years or 5 years younger than the onset of family
disease. The detection rate of small cancers was 96.1%, 47%
and 42.8% for MRI, ultrasound and mammography, respectively.
The ability to distinguish between cancer and non-cancerous
masses occurred 95.1%, 94.3% and 88.4% of the time in MRI,
ultrasound and mammography, respectively. MRI screening resulted
in the fewest unnecessary biopsies.
These results indicate that MRI has the highest detection
rate of small cancers and leads to the lowest rate of unnecessary
biopsies compared to ultrasound and mammography in young women
at a high risk of developing breast cancer. The researchers
suggest that MRI is superior to ultrasound and mammography
in this group of women and should be considered to replace
mammgraphy as the most effective screening measure. Patients
at a high risk of developing breast cancer may wish to speak
with their physician about the risks and benefits of MRI screening.
Reference: Kuhl C, Schrading S, Leutner C, et al. Surveillance
of "high risk" women with proven or suspected familial
(hereditary) breast cancer: First mid-term results of a multi-modality
clinical screening trial. Proceedings from the 39th annual
meeting of the American Society of Clinical Oncology. Plenary
Session. Abstract #4. May 2003.
© CancerConsultants.com
|